Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 79.70
0.00 (0.00%)
Feb 19, 2026, 9:59 AM IDT
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 260.38 million as of February 19, 2026. Its market cap has increased by 73.26% in one year.
Market Cap
260.38M
Enterprise Value
319.17M
Revenue
84.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
79.70
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 260.38M, an increase of 787.86%. That is a compound annual growth rate of 35.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 260.38M | -0.99% |
| Dec 31, 2025 | 263.00M | 76.79% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 603.82M |
| Matricelf | 151.55M |
| Clal Biotechnology Industries | 48.62M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 29.83M |
| XTL Biopharmaceuticals | 26.49M |
| Evogene | 26.29M |
| Purple Biotech | 18.58M |